Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: a prognostic entity

Cancer Lett. 2008 Jun 18;264(2):274-80. doi: 10.1016/j.canlet.2008.01.038. Epub 2008 Mar 10.

Abstract

Patients with malignancies often possess increased concentrations of cell-free serum DNA. In this study, we investigated serum DNA levels in each 45 patients with bladder cancer (BCA) undergoing radical cystectomy and with benign prostate hyperplasia. A quantitative real-time PCR was used to amplify a 124 bp (PTGS2; mostly apoptotic origin) and a 271 bp (Reprimo; mostly necrotic origin) DNA fragment. Changes in the origin of DNA fragments were specified as the Apoptosis Index (AI, ratio of 124 bp/271 bp fragments). Small and large fragments were increased (p<0.001 and p=0.041) in BCA patients. The AI increase suggests that DNA fragmentation was mostly (p<0.001) caused by apoptosis. High levels of small DNA fragments distinguished between BCA and BPH with high sensitivity (96%) and moderate specificity (62%). DNA levels and the AI were not correlated with clinicopathological parameters. However, an increased AI was correlated with BCA-specific mortality in a multivariate analysis (p=0.011) indicating that the AI is an independent prognostic factor. Thus, cell-free DNA seems to be a useful prognostic marker in patients with BCA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Apoptosis / physiology*
  • Biomarkers, Tumor / blood*
  • DNA / blood*
  • DNA Fragmentation*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Prostatic Hyperplasia / blood
  • ROC Curve
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sensitivity and Specificity
  • Serum
  • Urinary Bladder Neoplasms / blood*

Substances

  • Biomarkers, Tumor
  • DNA